Cell Viability Assay with 3D Prostate Tumor Spheroids
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature..
WST-8 (Cell Counting Kit 8; CCK-8) is the last generation tetrazolium-based cell viability assay and has recently been accepted as a validated method for measuring the cell viability of 3D in vitro models. Here, we describe how to form 3D prostate tumor spheroids using the polyHEMA technique, apply drug treatments and WST-8 assay to these spheroids, and calculate their cell viability. The advantages of our protocol are the formation of spheroids without adding extracellular matrix components, and the elimination of the critique handling process needed for transferring spheroids. Although this protocol exemplifies the determination of percentage cell viability in PC-3 prostate tumor spheroids, it can be adapted and optimized for other prostate cell lines and other types of cancers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2645 |
|---|---|
| Enthalten in: |
Methods in molecular biology (Clifton, N.J.) - 2645(2023) vom: 18., Seite 263-275 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oner, Ezgi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.05.2023 Date Revised 23.05.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/978-1-0716-3056-3_17 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357051629 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357051629 | ||
| 003 | DE-627 | ||
| 005 | 20231226071747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/978-1-0716-3056-3_17 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1190.xml |
| 035 | |a (DE-627)NLM357051629 | ||
| 035 | |a (NLM)37202626 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oner, Ezgi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cell Viability Assay with 3D Prostate Tumor Spheroids |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.05.2023 | ||
| 500 | |a Date Revised 23.05.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a WST-8 (Cell Counting Kit 8; CCK-8) is the last generation tetrazolium-based cell viability assay and has recently been accepted as a validated method for measuring the cell viability of 3D in vitro models. Here, we describe how to form 3D prostate tumor spheroids using the polyHEMA technique, apply drug treatments and WST-8 assay to these spheroids, and calculate their cell viability. The advantages of our protocol are the formation of spheroids without adding extracellular matrix components, and the elimination of the critique handling process needed for transferring spheroids. Although this protocol exemplifies the determination of percentage cell viability in PC-3 prostate tumor spheroids, it can be adapted and optimized for other prostate cell lines and other types of cancers | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 3D in vitro models | |
| 650 | 4 | |a Cytotoxicity | |
| 650 | 4 | |a PolyHEMA method | |
| 650 | 4 | |a Prostaspheres | |
| 650 | 4 | |a Prostate cancer | |
| 650 | 4 | |a Three-dimensional cell culture | |
| 650 | 4 | |a Tumor spheroids | |
| 650 | 4 | |a Ultra-low attachment surface | |
| 650 | 4 | |a WST-8 (Cell Counting Kit-8, CCK-8) cell viability assay | |
| 700 | 1 | |a Gray, Steven G |e verfasserin |4 aut | |
| 700 | 1 | |a Finn, Stephen P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Methods in molecular biology (Clifton, N.J.) |d 1984 |g 2645(2023) vom: 18., Seite 263-275 |w (DE-627)NLM074849794 |x 1940-6029 |7 nnns |
| 773 | 1 | 8 | |g volume:2645 |g year:2023 |g day:18 |g pages:263-275 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-0716-3056-3_17 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2645 |j 2023 |b 18 |h 263-275 | ||